Neuroprotective role of herbal alternatives in circumventing Alzheimer’s disease through multi-targeting approach - a review

References

• Christidi F, Migliaccio R, Santamaría-García H, et al. Social cognition dysfunctions in neurodegenerative diseases: neuroanatomical correlates and clinical implications. Behav Neurol. 2018;2018:1849794.
   PubMed Web of Science ®Google Scholar
• Więckowska A, Kołaczkowski M, Bucki A, et al. Novel multi-target-directed ligands for Alzheimer’s disease: combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation. Eur J Med Chem. 2016;124:63–81.
   PubMed Web of Science ®Google Scholar
• Guerreiro R, Bras J. The age factor in Alzheimer’s disease. Genome Med. 2015;7(1):106.
   PubMedGoogle Scholar
• Münch G, Schinzel R, Loske C, et al. Alzheimer’s disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm. 1998;105(4):439–461. DOI:10.1007/s007020050069.
   PubMed Web of Science ®Google Scholar
• LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci. 2007;8(7):499–509.
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Reddy PH. Therapeutics of neurotransmitters in Alzheimer’s Disease. J Alzheimers Dis. 2017;57(4):1049–1069.
   PubMed Web of Science ®Google Scholar
• Colovic MB, Krstic DZ, Lazarevic-Pasti TD, et al. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11(3):315–335. DOI:10.2174/1570159X11311030006.
   PubMed Web of Science ®Google Scholar
• Alvarez A, Opazo C, Alarcón R, et al. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol. 1997;272(3):348–361. DOI:10.1006/jmbi.1997.1245.
   PubMed Web of Science ®Google Scholar
• Darvesh S, Cash MK, Reid GA, et al. Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2012;71(1):2–14. DOI:10.1097/NEN.0b013e31823cc7a6.
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Alvarez A, Pérez CA, et al. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme. Neuron. 1996;16(4):881–891. DOI:10.1016/S0896-6273(00)80108-7.
   PubMed Web of Science ®Google Scholar
• Ahn JY, Kim S, Jung SE, et al. Effect of licorice (Glycyrrhiza uralensis fisch) on amyloid-β-induced neurotoxicity in PC12 cells. Food Sci Biotechnol. 2010;19(5):1391–1395. DOI:10.1007/s10068-010-0198-4.
   Web of Science ®Google Scholar
• Chen GF, Xu TH, Yan Y, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205–1235. DOI:10.1038/aps.2017.28.
   PubMed Web of Science ®Google Scholar
• Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet. 2010;19(R1):R12–20.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Hardy J, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8(6):595–608.
   PubMed Web of Science ®Google Scholar
• Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005;48(21):6523–6543.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Carvalho C, Zhu X, et al. Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochim Biophys Acta. 2010;1802(1):2–10. DOI:10.1016/j.bbadis.2009.10.006.
   PubMed Web of Science ®Google Scholar
• Ittner LM, Ke YD, Delerue F, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell. 2010;142(3):387–397. DOI:10.1016/j.cell.2010.06.036.
   PubMed Web of Science ®Google Scholar
• Mietelska-Porowska A, Wasik U, Goras M, et al. Protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci. 2014;15(3):4671–4713. DOI:10.3390/ijms15034671.
   PubMed Web of Science ®Google Scholar
• Butler MS. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep. 2008;25(3):475–516.
   PubMed Web of Science ®Google Scholar
• Sengupta T, Vinayagam J, Singh R, et al. Plant-derived natural products for Parkinson’s disease therapy. Adv Neurobiol. 2016;12:415–496.
   PubMedGoogle Scholar
• Harvey A. Natural products in drug discovery. Drug Discov Today. 2008;13(19–20):894–901.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70(3):461–477.
   PubMed Web of Science ®Google Scholar
• Prakash S, Jain A. Antifungal activity and preliminay phytochemical studies of leaf extract of Solanum nigrum Linn. Int J Pharm Pharm Sci. 2011;3:352–355.
   Google Scholar
• Nampoothiri M, John J, Kumar N, et al. Modulatory role of Simvastatin against aluminium chloride-induced behavioural and biochemical changes in rats. Behav Neurol. 2015;2015:1–9.
   Web of Science ®Google Scholar
• Murray AP, Faraoni MB, Castro MJ, Alza NP, and Cavallaro V. Natural AChE inhibitors from plants and their contribution to Alzheimer’s disease therapy. Curr. Neuropharmacol. 2013 Jul 1;11(4):388–413.
   Web of Science ®Google Scholar
• Ved HS, Best JM, and Dave JR. Comparative inhibition of acetylcholinesterase by Tacrine, Physostigmine and Huperzine in the adult rat brain. In Enzymes of the Cholinesterase Family, 1995 pp. 477–478. Boston, MA: Springer.
   Google Scholar
• Howes MJR, Perry NSL, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytother Res PTR. 2003;17(1):1–18.
   PubMed Web of Science ®Google Scholar
• Crowch CM, Okello EJ. Kinetics of acetylcholinesterase inhibitory activities by aqueous extracts of Acacia nilotica (L.) and Rhamnus prinoides (L’Her.). Afr J Pharm Pharmacol. 2009. [accessed May 4, 2020]. https://eprint.ncl.ac.uk/153908.
   Google Scholar
• Vinutha B, Prashanth D, Salma K, et al. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J Ethnopharmacol. 2007;109(2):359–363. DOI:10.1016/j.jep.2006.06.014.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Kumar V, Houghton PJ. Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity. Phytother Res. 2007;21(12):1142–1145.
   PubMed Web of Science ®Google Scholar
• Bonesi M, Menichini F, Tundis R, et al. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents. J Enzyme Inhib Med Chem. 2010;25(5):622–628. DOI:10.3109/14756360903389856.
   PubMed Web of Science ®Google Scholar
• Ingkaninan K, Temkitthawon P, Chuenchom K, et al. Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies. J Ethnopharmacol. 2003;89(2–3):261–264. DOI:10.1016/j.jep.2003.08.008.
   PubMed Web of Science ®Google Scholar
• Tundis R, Menichini F, Conforti F, et al. A potential role of alkaloid extracts from Salsola species (Chenopodiaceae) in the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem. 2009;24(3):818–824. DOI:10.1080/14756360802399662.
   PubMed Web of Science ®Google Scholar
• Elufioye TO, Obuotor EM, Sennuga AT, et al. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some selected Nigerian medicinal plants. Rev Bras Farmacogn. 2010;20(4):472–477. DOI:10.1590/S0102-695X2010000400002.
   Google Scholar
• Cortes N, Posada-Duque RA, and Alvarez R, et al. Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: a comparative study. Life Sci. 2015 Feb 1;122:42–50.
   PubMed Web of Science ®Google Scholar
• Fawole OA, Amoo SO, Ndhlala AR, et al. Anti-inflammatory, anticholinesterase, antioxidant and phytochemical properties of medicinal plants used for pain-related ailments in South Africa. J Ethnopharmacol. 2010;127(2):235–241. DOI:10.1016/j.jep.2009.11.015.
   PubMed Web of Science ®Google Scholar
• Haznedaroglu MZ, Gokce G. Comparison of anti-acetylcholinesterase activity of bulb and leaf extracts of Sternbergia candida Mathew & T. Baytop. Acta Biol Hung. 2014;65(4):396–404.
   Web of Science ®Google Scholar
• Moyo M, Ndhlala AR, Finnie JF, et al. Phenolic composition, antioxidant and acetylcholinesterase inhibitory activities of Sclerocarya birrea and Harpephyllum caffrum (Anacardiaceae) extracts. Food Chem. 2010;123(1):69–76. DOI:10.1016/j.foodchem.2010.03.130.
   Web of Science ®Google Scholar
• Benamar H, Tomassini L, Venditti A, et al. Acetylcholinesterase inhibitory activity of pyrrolizidine alkaloids from Echium confusum Coincy. Nat Prod Res. 2017;31(11):1277–1285.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Liu XQ, Kim YH, et al. Chemical constituents and their acetyl cholinesterase inhibitory and antioxidant activities from leaves of Acanthopanax henryi: potential complementary source against Alzheimer’s disease. Arch Pharm Res. 2014;37(5):606–616. DOI:10.1007/s12272-013-0252-x.
   PubMed Web of Science ®Google Scholar
• Załuski D, Kuźniewski R. In vitro Anti-AChE, Anti-BuChE, and Antioxidant Activity of 12 extracts of Eleutherococcus species. Oxid Med Cell Longev. 2016;2016:4135135.
   Web of Science ®Google Scholar
• Wszelaki N, Kuciun A, Kiss AK. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity. Acta Pharm Zagreb Croat. 2010;60(1):119–128.
   Web of Science ®Google Scholar
• Chougouo RDK, Nguekeu YMM, Dzoyem JP, et al. Anti-inflammatory and acetylcholinesterase activity of extract, fractions and five compounds isolated from the leaves and twigs of Artemisia annua growing in Cameroon. SpringerPlus. 2016;5(1):1525.
   PubMedGoogle Scholar
• Niño J, Hernández JA, Correa YM, et al. In vitro inhibition of acetylcholinesterase by crude plant extracts from Colombian flora. Mem Inst Oswaldo Cruz. 2006;101(7):783–785. DOI:10.1590/S0074-02762006000700013.
   Web of Science ®Google Scholar
• Bakthira H, Awadh Ali NA, Arnold N, et al. Anticholinesterase activity of endemic plant extracts from Soqotra. Afr J Tradit Complement Altern Med. 2011;8(3):296–299. DOI:10.4314/ajtcam.v8i3.65292.
   Google Scholar
• Besbes Hlila M, Omri A, Ben Jannet H, et al. Phenolic composition, antioxidant and anti-acetylcholinesterase activities of the Tunisian Scabiosa arenaria. Pharm Biol. 2013;51(5):525–532. DOI:10.3109/13880209.2012.746713.
   Web of Science ®Google Scholar
• Kamal Z, Ullah F, and Ayaz M, et al. Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer’s and other neurological disorders. Biol Res. 2015 Dec;48(1):21. DOI:10.1186/s40659-015-0011-1.
   Google Scholar
• Feitosa CM, Freitas RM, Luz NNN, et al. Acetylcholinesterase inhibition by somes promising Brazilian medicinal plants. Braz J Biol Rev Brasleira Biol. 2011;71(3):783–789.
   PubMed Web of Science ®Google Scholar
• Cespedes CL, Balbontin C, Avila JG, et al. Inhibition on cholinesterase and tyrosinase by alkaloids and phenolics from Aristotelia chilensis leaves. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2017;109(Pt 2):984–995. DOI:10.1016/j.fct.2017.05.009.
   PubMedGoogle Scholar
• Pisano MB, Cosentino S, Viale S, et al. Biological Activities of aerial parts Extracts of Euphorbia characias. BioMed Res Int. 2016;2016:1538703.
   PubMed Web of Science ®Google Scholar
• Saleem H, Ahmad I, Shahid MN, et al. In vitro acetylcholinesterase and butyrylcholinesterase inhibitory potentials of jatropha gossypifolia plant extracts. Acta Pol Pharm. 2016;73(2):419–423.
   PubMed Web of Science ®Google Scholar
• Orhan I, Sener B, Choudhary MI, et al. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J Ethnopharmacol. 2004;91(1):57–60. DOI:10.1016/j.jep.2003.11.016.
   PubMed Web of Science ®Google Scholar
• Sonibare MA, Ayoola IO, Elufioye TO. Antioxidant and acetylcholinesterase inhibitory activities of leaf extract and fractions of Albizia adianthifolia (Schumach) W.F. Wright J Basic Clin Physiol Pharmacol. 2017;28(2):143–148.
   Google Scholar
• Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med. 2007;3(1):95–101. DOI:10.1016/j.nano.2006.12.001.
   PubMed Web of Science ®Google Scholar
• Rauter AP, Martins A, Lopes R, et al. Bioactivity studies and chemical profile of the antidiabetic plant Genista tenera. J Ethnopharmacol. 2009;122(2):384–393. DOI:10.1016/j.jep.2008.10.011.
   PubMed Web of Science ®Google Scholar
• Llorent-Martínez EJ, Ortega-Barrales P, Zengin G, et al. Evaluation of antioxidant potential, enzyme inhibition activity and phenolic profile of Lathyrus cicera and Lathyrus digitatus: potential sources of bioactive compounds for the food industry. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2017;107(Pt B):609–619. DOI:10.1016/j.fct.2017.03.002.
   PubMedGoogle Scholar
• Satheeshkumar N, Mukherjee PK, Bhadra S, et al. Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. Phytomedicine Int J Phytother Phytopharm. 2010;17(3–4):292–295.
   Web of Science ®Google Scholar
• Keskin C. Antioxidant, anticancer and anticholinesterase activities of flower, fruit and seed extracts of Hypericum amblysepalum HOCHST. Asian Pac J Cancer Prev APJCP. 2015;16(7):2763–2769.
   Google Scholar
• Béjaoui A, Ben Salem I, Rokbeni N, et al. Bioactive compounds from Hypericum humifusum and Hypericum perfoliatum: inhibition potential of polyphenols with acetylcholinesterase and key enzymes linked to type-2 diabetes. Pharm Biol. 2017;55(1):906–911. DOI:10.1080/13880209.2016.1270973.
   PubMed Web of Science ®Google Scholar
• Zachow LL, Ávila JM, Saldanha GA, et al. Chemical composition and evaluation of prolyl oligopeptidase and acetylcholinesterase inhibitory activities of Leonurus Sibiricus L. from Brazil. Nat Prod Res. 2017;31(12):1459–1463. DOI:10.1080/14786419.2016.1255890.
   PubMed Web of Science ®Google Scholar
• Vladimir-Knezevic S, Blazekovic B, Kindl M, et al. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family. Mol Basel Switz. 2014;19(1):767–782.
   Google Scholar
• Loizzo MR, Menichini F, Conforti F, et al. Chemical analysis, antioxidant, antiinflammatory and anticholinesterase activities of Origanum ehrenbergii Boiss and Origanum syriacum L. essential oils. Food Chem. 2009;117(1):174–180. DOI:10.1016/j.foodchem.2009.03.095.
   Web of Science ®Google Scholar
• Şenol FS, Orhan I, Celep F, et al. Survey of 55 Turkish Salvia taxa for their acetylcholinesterase inhibitory and antioxidant activities. Food Chem. 2010;120(1):34–43. DOI:10.1016/j.foodchem.2009.09.066.
   Web of Science ®Google Scholar
• Lin HQ, Ho MT, Lau LS, et al. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer’s disease. Chem Biol Interact. 2008;175(1–3):352–354. DOI:10.1016/j.cbi.2008.05.030.
   Web of Science ®Google Scholar
• Ferhat M, Erol E, Beladjila KA, et al. Antioxidant, anticholinesterase and antibacterial activities of Stachys guyoniana and Mentha aquatica. Pharm Biol. 2017;55(1):324–329. DOI:10.1080/13880209.2016.1238488.
   PubMed Web of Science ®Google Scholar
• Jung HA, Ali MY, Jung HJ, et al. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases. J Ethnopharmacol. 2016;191:152–160.
   PubMed Web of Science ®Google Scholar
• Cavallaro V, Alza NP, Murray MG, et al. Alkaloids from Habranthus tubispathus and H. jamesonii, two amaryllidaceae with acetyl- and butyrylcholinesterase inhibition activity. Nat Prod Commun. 2014;9(2):159–162.
   Web of Science ®Google Scholar
• Tung BT, Hai NT, Thu DK. Antioxidant and acetylcholinesterase inhibitory activities in vitro of different fraction of Huperzia squarrosa (Forst.) Trevis extract and attenuation of scopolamine-induced cognitive impairment in mice. J Ethnopharmacol. 2017;198:24–32.
   Web of Science ®Google Scholar
• Tappayuthpijarn P, Itharat A, Makchuchit S. Acetylcholinesterase inhibitory activity of Thai traditional nootropic remedy and its herbal ingredients. J Med Assoc Thail Chotmaihet Thangphaet. 2011;94(7):S183–189.
   Google Scholar
• Kuk EB, Jo AR, Oh SI, et al. Anti-Alzheimer’s disease activity of compounds from the root bark of Morus alba L. Arch Pharm Res. 2017;40(3):338–349. DOI:10.1007/s12272-017-0891-4.
   PubMed Web of Science ®Google Scholar
• Gasca CA, Castillo WO, Takahashi CS, et al. Assessment of anti-cholinesterase activity and cytotoxicity of cagaita (Eugenia dysenterica) leaves. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2017;109(2):996–1002. DOI:10.1016/j.fct.2017.02.032.
   Google Scholar
• Uddin MN, Afrin R, Uddin MJ, et al. Vanda roxburghii chloroform extract as a potential source of polyphenols with antioxidant and cholinesterase inhibitory activities: identification of a strong phenolic antioxidant. BMC Complement Altern Med. 2015;15(1):195. DOI:10.1186/s12906-015-0728-y.
   Google Scholar
• Adsersen A, Gauguin B, Gudiksen L, et al. Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity. J Ethnopharmacol. 2006;104(3):418–422. DOI:10.1016/j.jep.2005.09.032.
   PubMed Web of Science ®Google Scholar
• Georgiev MI, Alipieva K, Orhan IE. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems. Phytother Res PTR. 2012;26(2):313–316.
   Web of Science ®Google Scholar
• Ustun O, Senol FS, Kurkcuoglu M, et al. Investigation on chemical composition, anticholinesterase and antioxidant activities of extracts and essential oils of Turkish Pinus species and pycnogenol. Ind Crops Prod. 2012;38:115–123.
   Web of Science ®Google Scholar
• Khadri A, Neffati M, Smiti S, et al. Antioxidant, antiacetylcholinesterase and antimicrobial activities of Cymbopogon schoenanthus L. Spreng (lemon grass) from Tunisia. LWT - Food Sci Technol. 2010;43(2):331–336. DOI:10.1016/j.lwt.2009.08.004.
   Web of Science ®Google Scholar
• Saliu JA, Olabiyi AA. Aqueous extract of Securidaca longipendunculata Oliv. and Olax subscropioidea inhibits key enzymes (acetylcholinesterase and butyrylcholinesterase) linked with Alzheimer’s disease in vitro. Pharm Biol. 2017;55(1):252–257.
   PubMed Web of Science ®Google Scholar
• Carpinella MC, Andrione DG, Ruiz G, et al. Screening for acetylcholinesterase inhibitory activity in plant extracts from Argentina. Phytother Res PTR. 2010;24(2):259–263. DOI:10.1002/ptr.2923.
   PubMed Web of Science ®Google Scholar
• Wu P, Li F, Zhang J. Phytochemical compositions of extract from peel of hawthorn fruit, and its antioxidant capacity, cell growth inhibition, and acetylcholinesterase inhibitory activity. BMC Complement Altern Med. 2017;17(1):151.
   Google Scholar
• Kim CR, Choi SJ, Oh SS, et al. Rubus coreanus Miquel inhibits acetylcholinesterase activity and prevents cognitive impairment in a mouse model of dementia. J Med Food. 2013;16(9):785–792. DOI:10.1089/jmf.2012.2663.
   PubMed Web of Science ®Google Scholar
• Osama A, Awadelkarim S, Ali A. Antioxidant activity, acetylcholinesterase inhibitory potential and phytochemical analysis of Sarcocephalus latifolius Sm. bark used in traditional medicine in Sudan. BMC Complement Altern Med. 2017;17(1):270.
   Google Scholar
• Das A, Shanker G, Nath C, et al. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav. 2002;73(4):893–900. DOI:10.1016/S0091-3057(02)00940-1.
   Web of Science ®Google Scholar
• Liu YC, Su J, Wu XD, et al. Five new Lycopodium alkaloids from the aerial parts of Phlegmariurus henryi. Fitoterapia. 2016;115:148–154.
   Web of Science ®Google Scholar
• Lam CW, Wakeman A, James A, et al. Bioactive steroidal alkaloids from Buxus macowanii Oliv. Steroids. 2015;95:73–79.
   PubMed Web of Science ®Google Scholar
• -Rahman A-U, Khalid A, Sultana N, et al. New natural cholinesterase inhibiting and calcium channel blocking quinoline alkaloids. J Enzyme Inhib Med Chem. 2006;21(6):703–710. DOI:10.1080/14756360600889708.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhou S, Zhang M, et al. An in vitro AChE inhibition assay combined with UF-HPLC-ESI-Q-TOF/MS approach for screening and characterizing of AChE inhibitors from roots of Coptis chinensis. Franch J Pharm Biomed Anal. 2016;120:235–240.
   PubMed Web of Science ®Google Scholar
• Andrade MT, Lima JA, Pinto AC, et al. Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme. Bioorg Med Chem. 2005;13(12):4092–4095. DOI:10.1016/j.bmc.2005.03.045.
   Web of Science ®Google Scholar
• Shin KY, Kim KY, Suh YH. Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models. Korean J Physiol Pharmacol Off J Korean Physiol Soc Korean Soc Pharmacol. 2017;21(1):55–64.
   Web of Science ®Google Scholar
• Chlebek J, Novák Z, Kassemová D, et al. Isoquinoline Alkaloids from Fumaria officinalis L. and their biological activities related to Alzheimer’s disease. Chem Biodivers. 2016;13(1):91–99. DOI:10.1002/cbdv.201500033.
   Web of Science ®Google Scholar
• Lima JA, Costa RS, Epifânio RA, et al. Geissospermum vellosii stembark: anticholinesterase activity and improvement of scopolamine-induced memory deficits. Pharmacol Biochem Behav. 2009;92(3):508–513. DOI:10.1016/j.pbb.2009.01.024.
   PubMed Web of Science ®Google Scholar
• Khalid A, Anjum S, Khan , MR, et al. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases. Bioorg Med Chem. 2004 May;12(9):1995–2003. DOI:10.1016/j.bmc.2004.03.002.
   Web of Science ®Google Scholar
• Ahmad H, Ahmad S, Khan E, et al. Isolation, crystal structure determination and cholinesterase inhibitory potential of isotalatizidine hydrate from Delphinium denudatum. Pharm Biol. 2017;55(1):680–686. DOI:10.1080/13880209.2016.1240207.
   PubMed Web of Science ®Google Scholar
• Choudhary MI, Nawaz SA, Azim , MK, et al. Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer’s disease therapy. Biochem Biophys Res Commun. 2005 Jul;332(4):1171–1177.
   Web of Science ®Google Scholar
• Sichaem J, Rojpitikul T, Sawasdee P, et al. Furoquinoline Alkaloids from the Leaves of Evodia lepta as potential Cholinesterase inhibitors and their molecular docking. Nat Prod Commun. 2015;10(8):1359–1362.
   Web of Science ®Google Scholar
• Dall’Igna OP, Fett P, Gomes MW, et al. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25–35)-induced cognitive deficits in mice. Exp Neurol. 2007;203(1):241–245. DOI:10.1016/j.expneurol.2006.08.008.
   PubMed Web of Science ®Google Scholar
• Triggle DJ, Mitchell JM, Filler RB. The Pharmacology of Physostigmine.1998. [accessed May 10, 2020]. https://www.semanticscholar.org/paper/The-Pharmacology-of-Physostigmine-Triggle-Mitchell/
   Google Scholar
• Fadaeinasab M, Basiri A, Kia Y, et al. New Indole Alkaloids from the Bark of Rauvolfia Reflexa and their Cholinesterase Inhibitory Activity. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2015;37(5):1997–2011. DOI:10.1159/000438560.
   Google Scholar
• Sichaem J, Ingkaninan K, Tip-Pyang S. A novel pyrrole alkaloid from the fruit peels of Strychnos nux-blanda. Nat Prod Res. 2017;31(2):149–154.
   PubMed Web of Science ®Google Scholar
• Rollinger JM, Schuster D, Baier E, et al. Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana. J Nat Prod. 2006;69(9):1341–1346. DOI:10.1021/np060268p.
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Seo UM, Zhao BT, et al. Ellagitannin and flavonoid constituents from Agrimonia pilosa Ledeb. with their protein tyrosine phosphatase and acetylcholinesterase inhibitory activities. Bioorg Chem. 2017;72:293–300.
   PubMed Web of Science ®Google Scholar
• Labed A, Ferhat M, Labed-Zouad I, et al. Compounds from the pods of Astragalus armatus with antioxidant, anticholinesterase, antibacterial and phagocytic activities. Pharm Biol. 2016;54(12):3026–3032. DOI:10.1080/13880209.2016.1200632.
   PubMed Web of Science ®Google Scholar
• Heo HJ, Kim MJ, Lee JM, et al. Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement Geriatr Cogn Disord. 2004;17(3):151–157. DOI:10.1159/000076349.
   PubMed Web of Science ®Google Scholar
• Pereira VV, Duarte LP, Silva RR, et al. New jacaranone glucoside from Jacaranda oxyphylla leaves. Nat Prod Res. 2016;30(21):2421–2428. DOI:10.1080/14786419.2016.1195378.
   PubMed Web of Science ®Google Scholar
• Ren Y, Houghton PJ, Hider RC, et al. Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. Planta Med. 2004;70(3):201–204.
   PubMed Web of Science ®Google Scholar
• Kang YQ, Zhou JC, Fan PH, et al. Scapaundulin C, a novel labdane diterpenoid isolated from Chinese liverwort Scapania undulate, inhibits acetylcholinesterase activity. Chin J Nat Med. 2015;13(12):933–936. DOI:10.1016/S1875-5364(15)30100-X.
   Web of Science ®Google Scholar
• Chung YK, Heo HJ, Kim EK, et al. Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase. Mol Cells. 2001;11(2):137–143.
   PubMed Web of Science ®Google Scholar
• Chen HW, He XH, Yuan R, et al. Sesquiterpenes and a monoterpenoid with acetylcholinesterase (AchE) inhibitory activity from Valeriana officinalis var. latiofolia in vitro and in vivo. Fitoterapia. 2016;110:142–149.
   PubMed Web of Science ®Google Scholar
• Miyazawa M, Watanabe H, Kameoka H. Inhibition of Acetylcholinesterase activity by Monoterpenoids with a p-Menthane skeleton. J Agric Food Chem. 1997;45(3):677–679.
   Web of Science ®Google Scholar
• Dzoyem JP, Tsamo AT, Melong R, et al. Cytotoxicity, nitric oxide and acetylcholinesterase inhibitory activity of three limonoids isolated from Trichilia welwitschii (Meliaceae). Biol Res. 2015;48(1):57. DOI:10.1186/s40659-015-0049-0.
   PubMedGoogle Scholar
• Alves CQ, Lima LS, David JM, et al. In vitro acetylcholinesterase activity of peptide derivatives isolated from two species of Leguminosae. Pharm Biol. 2013;51(7):936–939. DOI:10.3109/13880209.2013.770536.
   PubMed Web of Science ®Google Scholar
• Hou YC, Chao PD, Chen SY. Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats. Am J Chin Med. 2000;28(3–4):379–384.
   Web of Science ®Google Scholar
• Kwak HM, Jeon SY, Sohng BH, et al. beta-Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch Pharm Res. 2005;28(12):1328–1332. DOI:10.1007/BF02977896.
   Web of Science ®Google Scholar
• O M, Mp L, B A, et al. Plants and their chemical compounds affecting betha-amyloid and secretase activity as potential sources of neuroprotective herbal medicinal products. Part 1. Herba Pol. 2010. [(accessed 2020 May 10]. http://agro.icm.edu.pl/agro/element-bwmeta1-element-agro/.
   Google Scholar
• Okello EJ, Savelev SU, Perry EK. In vitro anti-beta-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia. Phytother Res PTR. 2004;18(8):624–627.
   PubMed Web of Science ®Google Scholar
• Hardy J. Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci. 1997;20(4):154–159.
   PubMed Web of Science ®Google Scholar
• Lee YK, Yuk DY, Lee JW, et al. (-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. Brain Res. 2009;1250:164–174.
   PubMed Web of Science ®Google Scholar
• Descamps O, Spilman P, Zhang Q, et al. AβPP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for Alzheimer’s disease. J Alzheimers Dis JAD. 2013;37(2):343–355. DOI:10.3233/JAD-130578.
   Web of Science ®Google Scholar
• Buxbaum JD, Liu KN, Luo Y, et al. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem. 1998;273(43):27765–27767. DOI:10.1074/jbc.273.43.27765.
   PubMed Web of Science ®Google Scholar
• Allinson TMJ, Parkin ET, Turner AJ, et al. ADAMs family members as amyloid precursor protein α-secretases. J Neurosci Res. 2003;74(3):342–352. DOI:10.1002/jnr.10737.
   Web of Science ®Google Scholar
• Suh J, Choi SH, Romano DM, et al. ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function. Neuron. 2013;80(2):385–401. DOI:10.1016/j.neuron.2013.08.035.
   PubMed Web of Science ®Google Scholar
• Lichtenthaler SF. α-secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential. J Neurochem. 2011;116(1):10–21.
   Web of Science ®Google Scholar
• Postina R, Schroeder A, Dewachter I, et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest. 2004;113(10):1456–1464. DOI:10.1172/JCI20864.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Goldstein LE, Lahiri DK, et al. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer’s disease. Curr Med Chem. 2007;14(27):2848–2864. DOI:10.2174/092986707782360060.
   Web of Science ®Google Scholar
• De Strooper B, Vassar R, Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol. 2010;6(2):99–107.
   PubMed Web of Science ®Google Scholar
• Hong-Qi Y, Zhi-Kun S, Sheng-Di C. Current advances in the treatment of Alzheimer’s disease: focused on considerations targeting Aβ and tau. Transl Neurodegener. 2012;1(1):21.
   PubMedGoogle Scholar
• Adewusi EA, Steenkamp V. Medicinal plants and their derivatives with amyloid beta inhibitory activity as potential targets for drug discovery. Asian Pac J Trop Dis. 2015;5(6):430–440.
   Google Scholar
• Hanish Singh JC, Alagarsamy V, Diwan PV, et al. Neuroprotective effect of Alpinia galanga (L.) fractions on Aβ(25–35) induced amnesia in mice. J Ethnopharmacol. 2011;138(1):85–91. DOI:10.1016/j.jep.2011.08.048.
   Web of Science ®Google Scholar
• Yan JJ, Kim DH, Moon YS, et al. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(1):25–30. DOI:10.1016/S0278-5846(03)00168-4.
   PubMed Web of Science ®Google Scholar
• Limpeanchob N, Jaipan S, Rattanakaruna S, et al. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol. 2008;120(1):112–117. DOI:10.1016/j.jep.2008.07.039.
   PubMed Web of Science ®Google Scholar
• Jeong JC, Yoon CH, Lee WH, et al. Effects of Bambusae concretio Salicea (Chunchukhwang) on amyloid beta-induced cell toxicity and antioxidative enzymes in cultured rat neuronal astrocytes. J Ethnopharmacol. 2005;98(3):259–266. DOI:10.1016/j.jep.2004.12.034.
   Web of Science ®Google Scholar
• Ramesh BN, Indi SS, Rao KSJ. Anti-amyloidogenic property of leaf aqueous extract of Caesalpinia crista. Neurosci Lett. 2010;475(2):110–114.
   Web of Science ®Google Scholar
• Ogunruku OO, Oboh G, Passamonti S, et al. Capsicum annuum var. grossum (Bell Pepper) Inhibits β-Secretase Activity and β-Amyloid1–40 Aggregation. J Med Food. 2017;20(2):124–130. DOI:10.1089/jmf.2016.0077.
   PubMed Web of Science ®Google Scholar
• Gray NE, Sampath H, Zweig JA, et al. Centella asiatica Attenuates Amyloid-β-Induced oxidative stress and mitochondrial dysfunction. J Alzheimers Dis JAD. 2015;45(3):933–946. DOI:10.3233/JAD-142217.
   Web of Science ®Google Scholar
• Frydman-Marom A, Levin A, Farfara D, et al. Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models. PloS One. 2011;6(1):e16564. DOI:10.1371/journal.pone.0016564.
   PubMed Web of Science ®Google Scholar
• Papandreou MA, Kanakis CD, Polissiou MG, et al. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem. 2006;54(23):8762–8768. DOI:10.1021/jf061932a.
   PubMed Web of Science ®Google Scholar
• Batarseh YS, Bharate SS, Kumar V, et al. Crocus sativus extract tightens the blood-brain barrier, reduces amyloid β Load and related toxicity in 5XFAD Mice. ACS Chem Neurosci. 2017;8(8):1756–1766. DOI:10.1021/acschemneuro.7b00101.
   PubMed Web of Science ®Google Scholar
• Kang IJ, Jeon YE, Yin XF, et al. Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2011;49(9):2252–2259. DOI:10.1016/j.fct.2011.06.023.
   Web of Science ®Google Scholar
• Bai Y, Tohda C, Zhu S, et al. Active components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid β(25–35)-induced neuritic atrophy in cultured rat cortical neurons. J Nat Med. 2011;65(3–4):417–423. DOI:10.1007/s11418-011-0509-y.
   Web of Science ®Google Scholar
• Lin YL, Tsay HJ, and Liao YF, et al. The components of Flemingia macrophylla attenuate amyloid β-protein accumulation by regulating amyloid β-protein metabolic pathway. Evid-Based Compl Altern Med ECAM. 2012;795843. DOI:10.1155/2012/795843.
   Google Scholar
• Lai CSW, Yu MS, Yuen WH, et al. Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res. 2008;1190:215–224.
   PubMed Web of Science ®Google Scholar
• Bastianetto S, Ramassamy C, Doré S, et al. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci. 2000;12(6):1882–1890. DOI:10.1046/j.1460-9568.2000.00069.x.
   PubMed Web of Science ®Google Scholar
• Sheeja Malar D, Beema Shafreen R, Karutha Pandian S, et al. Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia - An in vitro and in silico study. Pharm Biol. 2017;55(1):381–393. DOI:10.1080/13880209.2016.1241811.
   PubMed Web of Science ®Google Scholar
• Park H, Oh MS. Houttuyniae Herba protects rat primary cortical cells from Aβ(25–35)-induced neurotoxicity via regulation of calcium influx and mitochondria-mediated apoptosis. Hum Exp Toxicol. 2012;31(7):698–709.
   Web of Science ®Google Scholar
• Park TS, Ryu YK, Park HY, et al. Humulus japonicus inhibits the progression of Alzheimer’s disease in a APP/PS1 transgenic mouse model. Int J Mol Med. 2017;39(1):21–30. DOI:10.3892/ijmm.2016.2804.
   Web of Science ®Google Scholar
• Cao Z, Wang F, Xiu C, et al. Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer’s disease rats. Biomed Pharmacother Biomedecine Pharmacother. 2017;91:931–937.
   PubMed Web of Science ®Google Scholar
• Kraus B, Wolff H, Heilmann J, et al. Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells. Life Sci. 2007;81(11):884–894. DOI:10.1016/j.lfs.2007.07.020.
   Web of Science ®Google Scholar
• Ho YS, Yu MS, Lai CSW, et al. Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on beta-amyloid peptide neurotoxicity. Brain Res. 2007;1158:123–134.
   PubMed Web of Science ®Google Scholar
• Lee JW, Lee YK, Lee BJ, et al. Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol Biochem Behav. 2010;95(1):31–40. DOI:10.1016/j.pbb.2009.12.003.
   Web of Science ®Google Scholar
• Chun YS, Kim J, Chung S, et al. Protective roles of Monsonia angustifolia and its active compounds in experimental models of Alzheimer’s disease. J Agric Food Chem. 2017;65(15):3133–3140. DOI:10.1021/acs.jafc.6b04451.
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Tabuchi M, Yamaguchi T, et al. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti-aggregation effects on Alzheimer’s amyloid beta proteins in vitro and in vivo. J Neurochem. 2009;109(6):1648–1657. DOI:10.1111/j.1471-4159.2009.06069.x.
   PubMed Web of Science ®Google Scholar
• Hritcu L, Noumedem JA, Cioanca O, et al. Methanolic extract of Piper nigrum fruits improves memory impairment by decreasing brain oxidative stress in amyloid beta(1–42) rat model of Alzheimer’s disease. Cell Mol Neurobiol. 2014;34(3):437–449. DOI:10.1007/s10571-014-0028-y.
   PubMed Web of Science ®Google Scholar
• Hage S, Kienlen-Campard P, Octave JN, et al. In vitro screening on β-amyloid peptide production of plants used in traditional medicine for cognitive disorders. J Ethnopharmacol. 2010;131(3):585–591. DOI:10.1016/j.jep.2010.07.044.
   Web of Science ®Google Scholar
• Figueiró M, Ilha J, Linck VM, et al. The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model. Phytomedicine Int J Phytother Phytopharm. 2011;18(4):327–333.
   Web of Science ®Google Scholar
• Irie Y, Keung WM. Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-beta peptide. Brain Res. 2003;963(1–2):282–289.
   Web of Science ®Google Scholar
• Khodagholi F, Ashabi G. Dietary supplementation with Salvia sahendica attenuates memory deficits, modulates CREB and its down-stream molecules and decreases apoptosis in amyloid beta-injected rats. Behav Brain Res. 2013;241:62–69.
   Web of Science ®Google Scholar
• Soodi M, Saeidnia S, Sharifzadeh M, et al. Satureja bachtiarica ameliorate beta-amyloid induced memory impairment, oxidative stress and cholinergic deficit in animal model of Alzheimer’s disease. Metab Brain Dis. 2016;31(2):395–404. DOI:10.1007/s11011-015-9773-y.
   Web of Science ®Google Scholar
• Jeong EJ, Lee HK, Lee KY, et al. The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse. J Ethnopharmacol. 2013;146(1):347–354. DOI:10.1016/j.jep.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Ban JY, Cho SO, Koh SB, et al. Protection of amyloid beta protein (25–35)-induced neurotoxicity by methanol extract of Smilacis chinae rhizome in cultured rat cortical neurons. J Ethnopharmacol. 2006;106(2):230–237. DOI:10.1016/j.jep.2005.12.034.
   Web of Science ®Google Scholar
• Prema A, Thenmozhi AJ, Manivasagam T, et al. Fenugreek seed powder nullified aluminium chloride induced memory loss, biochemical changes, Aβ burden and apoptosis via regulating Akt/GSK3β signaling pathway. PloS One. 2016;11(11):e0165955. DOI:10.1371/journal.pone.0165955.
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Iwasaki K, Furukawa K, et al. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer’s beta-amyloid proteins. J Neurosci Res. 2006;84(2):427–433. DOI:10.1002/jnr.20891.
   PubMed Web of Science ®Google Scholar
• Mathew M, Subramanian S. In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract. Indian J Exp Biol. 2014;52(6):606–612.
   Web of Science ®Google Scholar
• Adewusi EA, Fouche G, Steenkamp V. Effect of four medicinal plants on amyloid-β induced neurotoxicity in SH-SY5Y cells. Afr J Tradit Complement Altern Med. 2013;10(4):6–11.
   Google Scholar
• Durairajan SSK, Yuan Q, Xie L, et al. Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty. Neurochem Int. 2008;52(4–5):741–750. DOI:10.1016/j.neuint.2007.09.006.
   Web of Science ®Google Scholar
• Chu YF, Chang WH, Black RM, et al. Crude caffeine reduces memory impairment and amyloid β(1–42) levels in an Alzheimer’s mouse model. Food Chem. 2012;135(3):2095–2102. DOI:10.1016/j.foodchem.2012.04.148.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Yan H, Tang XC. Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1–40) infused rats and human embryonic kidney 293 Swedish mutant cells. Neurosci Lett. 2004;360(1–2):21–24.
   Web of Science ®Google Scholar
• Shim SB, Lee SH, Chae KR, et al. Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice. Neurochem Res. 2008;33(9):1783–1788. DOI:10.1007/s11064-008-9629-5.
   Web of Science ®Google Scholar
• Xian YF, Lin ZX, and Mao QQ, et al. Bioassay-guided isolation of neuroprotective compounds from Uncaria rhynchophylla against beta-amyloid-induced neurotoxicity. Evid-Based Compl Altern Med ECAM. 2012 Jan 1;802625. DOI:10.1155/2012/802625.
   Google Scholar
• Xian YF, Lin ZX, Mao QQ, et al. Protective effect of isorhynchophylline against β-amyloid-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol. 2012;32(3):353–360. DOI:10.1007/s10571-011-9763-5.
   Web of Science ®Google Scholar
• He FQ, Qiu BY, Zhang XH, et al. Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer’s disease induced by amyloid-β(1–42). Brain Res. 2011;1384:89–96.
   PubMed Web of Science ®Google Scholar
• Han J, Qu Q, Qiao J, et al. Vincamine alleviates amyloid-β 25–35 Peptides-induced cytotoxicity in PC12 cells. Pharmacogn Mag. 2017;13(49):123–128. DOI:10.4103/0973-1296.196309.
   Web of Science ®Google Scholar
• Xu W, Yang L, Li J. Protection against β-amyloid-induced neurotoxicity by naturally occurring Z-ligustilide through the concurrent regulation of p38 and PI3-K/Akt pathways. Neurochem Int. 2016;100:44–51.
   Web of Science ®Google Scholar
• Kim TI, Lee YK, Park SG, et al. l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med. 2009;47(11):1601–1610. DOI:10.1016/j.freeradbiomed.2009.09.008.
   PubMed Web of Science ®Google Scholar
• Esposito G, De Filippis D, Maiuri MC, et al. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett. 2006;399(1–2):91–95. DOI:10.1016/j.neulet.2006.01.047.
   PubMed Web of Science ®Google Scholar
• Xiang S, Liu F, Lin J, et al. Fucoxanthin inhibits β-amyloid assembly and attenuates β-amyloid oligomer-induced cognitive impairments. J Agric Food Chem. 2017;65(20):4092–4102. DOI:10.1021/acs.jafc.7b00805.
   PubMed Web of Science ®Google Scholar
• Ban JY, Cho SO, Jeon SY. 3,4-dihydroxybenzoic acid from Smilacis chinae rhizome protects amyloid beta protein (25–35)-induced neurotoxicity in cultured rat cortical neurons. Neurosci Lett. 2007;420(2):184–188.
   PubMed Web of Science ®Google Scholar
• Na CS, Hong SS, Choi YH, et al. Neuroprotective effects of constituents of Eragrostis ferruginea against Aβ-induced toxicity in PC12 cells. Arch Pharm Res. 2010;33(7):999–1003. DOI:10.1007/s12272-010-0704-5.
   Web of Science ®Google Scholar
• Lee DS, Cha BY, Woo JT, et al. Acerogenin A from acer nikoense maxim prevents oxidative stress-induced neuronal cell death through Nrf2-mediated heme oxygenase-1 expression in mouse hippocampal HT22 cell line. Mol Basel Switz. 2015;20(7):12545–12557.
   Google Scholar
• Zhao L, Wang JL, Wang YR, et al. Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model. Brain Res. 2013;1492:33–45.
   PubMed Web of Science ®Google Scholar
• Tan JW, Kim MK. Neuroprotective effects of biochanin A against β-amyloid-induced neurotoxicity in PC12 cells via a mitochondrial-dependent apoptosis pathway. Mol Basel Switz. 2016;21(5):548.
   Google Scholar
• Sul D, Kim HS, Lee D, et al. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life Sci. 2009;84(9–10):257–262. DOI:10.1016/j.lfs.2008.12.001.
   PubMed Web of Science ®Google Scholar
• Lee C, Park GH, Kim C-Y, et al. [6]-Gingerol attenuates β-amyloid-induced oxidative cell death via fortifying cellular antioxidant defense system. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2011;49(6):1261–1269.
   PubMed Web of Science ®Google Scholar
• Feng HL, Fan H, Dang HZ, et al. Neuroprotective effect of curcumin to Aβ of double transgenic mice with Alzheimer’s disease. J Chin Mater Medica. 2014;39(19):3846–3849.
   Google Scholar
• Li L, Du J, Zou L, et al. The Neuroprotective effects of decursin isolated from Angelica gigas Nakai Against Amyloid β-protein-induced apoptosis in PC 12 Cells via a mitochondria-related caspase pathway. Neurochem Res. 2015;40(8):1555–1562. DOI:10.1007/s11064-015-1623-0.
   Web of Science ®Google Scholar
• Kiasalari Z, Heydarifard R, Khalili M, et al. Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer’s disease: an exploration of underlying mechanisms. Psychopharmacology (Berl). 2017;234(12):1841–1852. DOI:10.1007/s00213-017-4589-6.
   PubMed Web of Science ®Google Scholar
• Richard T, Poupard P, Nassra M, et al. Protective effect of ε-viniferin on β-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry. Bioorg Med Chem. 2011;19(10):3152–3155. DOI:10.1016/j.bmc.2011.04.001.
   PubMed Web of Science ®Google Scholar
• Mori T, Koyama N, Guillot-Sestier MV, et al. Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and Alzheimer-like pathology in transgenic mice. PloS One. 2013;8(2):e55774. DOI:10.1371/journal.pone.0055774.
   PubMed Web of Science ®Google Scholar
• Ban JY, Nguyen HTT, Lee HJ, et al. Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid beta protein (25–35) - induced toxicity in cultured rat cortical neurons. Biol Pharm Bull. 2008;31(1):149–153. DOI:10.1248/bpb.31.149.
   PubMed Web of Science ®Google Scholar
• Liu R, Meng F, Zhang L, et al. Luteolin isolated from the medicinal plant Elsholtzia rugulosa (Labiatae) prevents copper-mediated toxicity in β-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Mol Basel Switz. 2011;16(3):2084–2096.
   Google Scholar
• Cai L, Wang LF, Pan JP, et al. Neuroprotective effects of methyl 3,4-Dihydroxybenzoate against TBHP-induced oxidative damage in SH-SY5Y cells. Mol Basel Switz. 2016;21(8):1071.
   Google Scholar
• Onozuka H, Nakajima A, Matsuzaki K, et al. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer’s disease. J Pharmacol Exp Ther. 2008;326(3):739–744. DOI:10.1124/jpet.108.140293.
   PubMed Web of Science ®Google Scholar
• Kim DH, Kim S, Jeon SJ, et al. The effects of acute and repeated oroxylin A treatments on Abeta(25–35)-induced memory impairment in mice. Neuropharmacology. 2008;55(5):639–647. DOI:10.1016/j.neuropharm.2008.05.019.
   Web of Science ®Google Scholar
• Li J, Ji X, Zhang J, et al. Paeoniflorin attenuates Aβ25–35-induced neurotoxicity in PC12 cells by preventing mitochondrial dysfunction. Folia Neuropathol. 2014;52(3):285–290. DOI:10.5114/fn.2014.45569.
   Web of Science ®Google Scholar
• Yoon JH, Youn K, Ho CT. p-Coumaric acid and ursolic acid from Corni fructus attenuated β-amyloid(25–35)-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells. J Agric Food Chem. 2014;62(21):4911–4916.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu H, Zhao X, et al. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int. 2010;57(5):547–555. DOI:10.1016/j.neuint.2010.06.021.
   PubMed Web of Science ®Google Scholar
• Iuvone T, De Filippis D, Esposito G, et al. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther. 2006;317(3):1143–1149. DOI:10.1124/jpet.105.099317.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang YJ, Su Y, et al. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology. 2012;33(3):482–490. DOI:10.1016/j.neuro.2012.03.003.
   PubMed Web of Science ®Google Scholar
• Lee YW, Kim DH, Jeon SJ, et al. Neuroprotective effects of salvianolic acid B on an Aβ25–35 peptide-induced mouse model of Alzheimer’s disease. Eur J Pharmacol. 2013;704(1–3):70–77. DOI:10.1016/j.ejphar.2013.02.015.
   Web of Science ®Google Scholar
• Lu P, Mamiya T, Lu LL, et al. Silibinin attenuates amyloid beta(25–35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice. J Pharmacol Exp Ther. 2009;331(1):319–326. DOI:10.1124/jpet.109.155069.
   PubMed Web of Science ®Google Scholar
• Yin F, Liu J, Ji X, et al. Silibinin: a novel inhibitor of Aβ aggregation. Neurochem Int. 2011;58(3):399–403. DOI:10.1016/j.neuint.2010.12.017.
   PubMed Web of Science ®Google Scholar
• Kwon SH, Ma SX, Hwang JY, et al. Involvement of the Nrf2/HO-1 signaling pathway in sulfuretin-induced protection against amyloid beta 25–35 neurotoxicity. Neuroscience. 2015;304:14–28.
   PubMed Web of Science ®Google Scholar
• Zhao LX, Wang Y, Liu T, et al. α-Mangostin decreases β-amyloid peptides production via modulation of amyloidogenic pathway. CNS Neurosci Ther. 2017;23(6):526–534. DOI:10.1111/cns.12699.
   PubMed Web of Science ®Google Scholar
• Zhou YQ, Yang ZL, Xu L, et al. Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity. Cell Biol Int. 2009;33(10):1102–1110. DOI:10.1016/j.cellbi.2009.06.028.
   Web of Science ®Google Scholar
• Fujihara K, Koike S, Ogasawara Y, et al. Inhibition of amyloid β aggregation and protective effect on SH-SY5Y cells by triterpenoid saponins from the cactus Polaskia chichipe. Bioorg Med Chem. 2017;25(13):3377–3383. DOI:10.1016/j.bmc.2017.04.023.
   Web of Science ®Google Scholar
• Chen DL, Zhang P, Lin L, et al. Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol. 2013;33(6):837–850. DOI:10.1007/s10571-013-9950-7.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li C, Yin J, et al. Fucoidan, a sulfated polysaccharide from brown algae, improves cognitive impairment induced by infusion of Aβ peptide in rats. Environ Toxicol Pharmacol. 2012;33(2):304–311. DOI:10.1016/j.etap.2011.12.022.
   Web of Science ®Google Scholar
• Wang P, Liao W, Fang J, et al. A glucan isolated from flowers of Lonicera japonica Thunb. inhibits aggregation and neurotoxicity of Aβ42. Carbohydr Polym. 2014;110:142–147.
   PubMed Web of Science ®Google Scholar
• Wang H, Xu Y, Yan J, et al. Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury. Brain Res. 2009;1283:139–147.
   PubMed Web of Science ®Google Scholar
• Ji ZN, Dong TTX, Ye WC, et al. Ginsenoside Re attenuate beta-amyloid and serum-free induced neurotoxicity in PC12 cells. J Ethnopharmacol. 2006;107(1):48–52. DOI:10.1016/j.jep.2006.02.004.
   Web of Science ®Google Scholar
• Misiti F, Sampaolese B, Mezzogori D, et al. Protective effect of rhubarb derivatives on amyloid beta (1–42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic. Brain Res Bull. 2006;71(1–3):29–36. DOI:10.1016/j.brainresbull.2006.07.012.
   Web of Science ®Google Scholar
• Jayaprakasam B, Padmanabhan K, Nair MG. Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer’s disease. Phytother Res PTR. 2010;24(6):859–863.
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhou L, Sun M, et al. Xylocoside G reduces amyloid-β induced neurotoxicity by inhibiting NF-κB signaling pathway in neuronal cells. J Alzheimers Dis JAD. 2012;30(2):263–275. DOI:10.3233/JAD-2012-110779.
   Web of Science ®Google Scholar
• Seo JY, Lim SS, Kim J, et al. Alantolactone and Isoalantolactone prevent amyloid β25–35 -induced toxicity in mouse cortical neurons and scopolamine-induced cognitive impairment in mice. Phytother Res PTR. 2017;31(5):801–811. DOI:10.1002/ptr.5804.
   PubMed Web of Science ®Google Scholar
• Rasoolijazi H, Azad N, and Joghataei MT, et al. The protective role of carnosic acid against beta-amyloid toxicity in rats. Sci World J. 2013;917082. DOI:10.1155/2013/917082.
   Google Scholar
• Mei Z, Zhang F, Tao L, et al. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neurosci Lett. 2009;452(2):90–95. DOI:10.1016/j.neulet.2009.01.013.
   Web of Science ®Google Scholar
• Azadmehr A, Oghyanous KA, Hajiaghaee R, et al. Antioxidant and neuroprotective effects of Scrophularia striata extract against oxidative stress-induced neurotoxicity. Cell Mol Neurobiol. 2013;33(8):1135–1141. DOI:10.1007/s10571-013-9979-7.
   PubMed Web of Science ®Google Scholar
• Chen X, Guo C, Kong J. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 2012;7(5):376–385.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhou T, and Ziegler AC, et al. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev. 2017 Oct;2525967. DOI:10.1155/2017/2525967.
   Google Scholar
• Paola D, Domenicotti C, Nitti M, et al. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun. 2000;268(2):642–646. DOI:10.1006/bbrc.2000.2164.
   Web of Science ®Google Scholar
• Hampel H, Prvulovic D, Teipel S, et al. The future of Alzheimer’s disease: the next 10 years. Prog Neurobiol. 2011;95(4):718–728. DOI:10.1016/j.pneurobio.2011.11.008.
   PubMed Web of Science ®Google Scholar
• Wilkinson D. Pharmacotherapy of Alzheimer’s disease. Psychiatry. 2005;4(1):43–47.
   Google Scholar
• Witt A, Macdonald N, Kirkpatrick P. Memantine hydrochloride. Nat Rev Drug Discov. 2004;3(2):109–110.
   PubMed Web of Science ®Google Scholar
• Lleo A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer’s disease. Annu Rev Med. 2006;57(1):513–533.
   Google Scholar
• Mudher A, Lovestone S. Alzheimer’s disease-do tauists and baptists finally shake hands? Trends Neurosci. 2002;25(1):22–26.
   PubMed Web of Science ®Google Scholar
• Costantino L, Barlocco D. Designed multiple ligands: basic research vs clinical outcomes. Curr Med Chem. 2012;19(20):3353–3387.
   PubMed Web of Science ®Google Scholar
• Cavalli A, Bolognesi ML, Minarini A, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem. 2008;51(3):347–372. DOI:10.1021/jm7009364.
   PubMed Web of Science ®Google Scholar
• Nasir MN, Abdullah J, Habsah M, et al. Inhibitory effect of asiatic acid on acetylcholinesterase, excitatory post synapticpotential and locomotor activity. Phytomedicine. 2012;19(3–4):311–316. DOI:10.1016/j.phymed.2011.10.004.
   Web of Science ®Google Scholar
• Patil SP, Maki S, Khedkar SA, et al. Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance. J Nat Prod. 2010;73(7):1196–1202. DOI:10.1021/np900633j.
   Web of Science ®Google Scholar
• Zhang X, Wu J, Dou Y, et al. Asiatic acid protects primary neurons against C2-ceramide-induced apoptosis. Eur J Pharmacol. 2012;679(1–3):51–59. DOI:10.1016/j.ejphar.2012.01.006.
   PubMed Web of Science ®Google Scholar
• Jia L, Liu J, Song Z, et al. Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways. J Pharm Pharmacol. 2012;64(10):1510–1521. DOI:10.1111/j.2042-7158.2012.01529.x.
   PubMed Web of Science ®Google Scholar
• Ji HF, Shen L. Berberine: a potential multipotent natural product to combat Alzheimer’s disease. Mol Basel Switz. 2011;16(8):6732–6740.
   Google Scholar
• Baum L, Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. J Alzheimers Dis JAD. 2004;6(4):367–377–-449.
   Web of Science ®Google Scholar
• Hamaguchi T, Ono K, Yamada M. REVIEW: curcumin and Alzheimer’s disease. CNS Neurosci Ther. 2010;16(5):285–297.
   PubMed Web of Science ®Google Scholar
• Jaques JADS, Rezer JFP, Carvalho FB, et al. Curcumin protects against cigarette smoke-induced cognitive impairment and increased acetylcholinesterase activity in rats. Physiol Behav. 2012;106(5):664–669. DOI:10.1016/j.physbeh.2012.05.001.
   PubMed Web of Science ®Google Scholar
• Mutsuga M, Chambers JK, Uchida K, et al. Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer’s brain. J Vet Med Sci. 2012;74(1):51–57. DOI:10.1292/jvms.11-0307.
   PubMed Web of Science ®Google Scholar
• Narasingapa RB, Jargaval MR, Pullabhatla S, et al. Activation of α-secretase by curcumin-aminoacid conjugates. Biochem Biophys Res Commun. 2012;424(4):691–696. DOI:10.1016/j.bbrc.2012.07.010.
   Web of Science ®Google Scholar
• Villaflores OB, Chen YJ, Chen CP, et al. Curcuminoids and resveratrol as anti-Alzheimer agents. Taiwan J Obstet Gynecol. 2012;51(4):515–525. DOI:10.1016/j.tjog.2012.09.005.
   Web of Science ®Google Scholar
• Hoerr R, Noeldner M. Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment. CNS Drug Rev. 2002;8(2):143–158.
   PubMedGoogle Scholar
• Teismann P, Ferger B. Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release. Eur J Pharmacol. 2000;398(2):247–250.
   Web of Science ®Google Scholar
• Bieschke J, Russ J, Friedrich RP, et al. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci U S A. 2010;107(17):7710–7715. DOI:10.1073/pnas.0910723107.
   PubMed Web of Science ®Google Scholar
• Jeon SY, Bae K, Seong YH, et al. Green tea catechins as a BACE1 (beta-secretase) inhibitor. Bioorg Med Chem Lett. 2003;13(22):3905–3908. DOI:10.1016/j.bmcl.2003.09.018.
   Web of Science ®Google Scholar
• Mandel SA, Amit T, Weinreb O, et al. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci Ther. 2008;14(4):352–365. DOI:10.1111/j.1755-5949.2008.00060.x.
   PubMed Web of Science ®Google Scholar
• Smith A, Giunta B, Bickford PC, et al. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease. Int J Pharm. 2010;389(1–2):207–212. DOI:10.1016/j.ijpharm.2010.01.012.
   PubMed Web of Science ®Google Scholar
• Jiang H, Wang X, Huang L, et al. Benzenediol-berberine hybrids: multifunctional agents for Alzheimer’s disease. Bioorg Med Chem. 2011;19(23):7228–7235. DOI:10.1016/j.bmc.2011.09.040.
   Web of Science ®Google Scholar
• Yan JJ, Jung JS, Kim TK, et al. Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease. Biol Pharm Bull. 2013;36(1):140–143. DOI:10.1248/bpb.b12-00798.
   PubMed Web of Science ®Google Scholar
• Hoi CP, Ho YP, Baum L, et al. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother Res PTR. 2010;24(10):1538–1542. DOI:10.1002/ptr.3178.
   PubMed Web of Science ®Google Scholar
• Ono K, Li L, Takamura Y, et al. Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding. J Biol Chem. 2012;287(18):14631–14643. DOI:10.1074/jbc.M111.325456.
   PubMed Web of Science ®Google Scholar
• Shimmyo Y, Kihara T, Akaike A. Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: involvement of direct inhibition of caspase-3. J Neurosci Res. 2008;86(8):1836–1845.
   Web of Science ®Google Scholar
• Ali T, Yoon GH, Shah SA, et al. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus. Sci Rep. [Internet]. 2015;5(1). 10.1038/srep11708.
   Google Scholar
• Shah SA, Yoon GH, Chung SS, et al. Osmotin reduced amyloid beta (Aβ) burden by inhibiting SREBP2 expression in APP/PS1 mice. Mol Psychiatry. 2017;22(3):323. DOI:10.1038/mp.2017.12.
   Google Scholar
• Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem. 2010;112(6):1415–1430.
   Web of Science ®Google Scholar
• Choi CW, Choi YH, Cha MR, et al. In vitro BACE-1 inhibitory activity of resveratrol oligomers from the seed extract of Paeonia lactiflora. Planta Med. 2011;77(4):374–376. DOI:10.1055/s-0030-1250370.
   Web of Science ®Google Scholar
• Feng X, Liang N, Zhu D, et al. Resveratrol inhibits β-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PloS One. 2013;8(3):e59888. DOI:10.1371/journal.pone.0059888.
   Web of Science ®Google Scholar
• Frozza RL, Bernardi A, Hoppe JB, et al. Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules. Mol Neurobiol. 2013;47(3):1066–1080. DOI:10.1007/s12035-013-8401-2.
   PubMed Web of Science ®Google Scholar
• Vingtdeux V, Dreses-Werringloer U, and Zhao H, et al. Therapeutic potential of resveratrol in Alzheimer’s disease. BMC Neurosci. 2008 Dec;9(2):S6. DOI:10.1186/1471-2202-9-S2-S6.
   PubMedGoogle Scholar
• Braidy N, Jugder B-E, Poljak A, et al. Molecular targets of tannic acid in Alzheimer’s Disease. Curr Alzheimer Res. [Internet]. 2017;14(8). 10.2174/1567205014666170206163158.
   Google Scholar